Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Overview of the epidemiology, diagnosis, and disease progression associated with multiple sclerosis.
Natalizumab Therapy for Multiple Sclerosis.
Hyaluronan accumulation and arrested oligodendrocyte progenitor maturation in vanishing white matter disease.
Aquaporin-4 antibody-negative neuromyelitis optica: Distinct assay sensitivity-dependent entity.
Autologous hematopoietic stem cell transplantation in multiple sclerosis: A phase II trial.
B cells contribute to MS pathogenesis through antibody-dependent and antibody-independent mechanisms.
Pathology of Multiple Sclerosis.
T cell deficiency in spinal cord injury: altered locomotor recovery and whole-genome transcriptional analysis.
Phenytoin protects spinal cord axons and preserves axonal conduction and neurological function in a model of neuroinflammation in vivo.
Frequency and economic impact of comorbid cardiac conditions with multiple sclerosis.
Natalizumab saturation: biomarker for individual treatment holiday after natalizumab withdrawal?
Aging and multiple sclerosis.
A RARE CASE OF ODONTOGENIC PARAINFECTIOUS INTRAORBITAL OPTIC NEURITIS WITH THE ABSENCE OF CLINICAL MANIFESTATION OF ORBITAL CELLULITIS.
Prognostic factors of acute partial transverse myelitis.
Hierarchical conditional random fields for detection of gad-enhancing lesions in multiple sclerosis.
Multiple sclerosis susceptibility loci do not alter clinical and MRI outcomes in clinically isolated syndrome.
Hope for a rare disease: eculizumab in neuromyelitis optica.
Protective Effects of 7,8-Dihydroxyflavone on Retinal Ganglion and RGC-5 Cells Against Excitotoxic and Oxidative Stress.
Association of multiple sclerosis with restless legs syndrome and other sleep disorders in women.
Carnitine for fatigue in multiple sclerosis.
Melatonin Contributes to the Seasonality of Multiple Sclerosis Relapses.
[Neuromyelitis optica and anti-aquaporin 4 antibody].
Long-Term Data of Efficacy, Safety and Tolerability in a Real Life Setting of THC/CBD Oromucosal Spray-Treated Multiple Sclerosis Patients.
The Communicative Participation Item Bank (CPIB): Item bank calibration and development of a disorder-generic short form.
Review series on immune responses in neurodegenerative diseases: Oligodendrocyte-microglia cross-talk in the CNS.
Pages
« first
‹ previous
…
248
249
250
251
252
253
254
255
256
…
next ›
last »